Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

The Effect of a Structured Workplace Exercise Program on 360-Degree Performance Evaluation, Job Motivation, Productivity, and Quality of Work Life (PADRA-EXER)

11 de setembro de 2026 atualizado por: Zinat Ebrahimi, Islamic Azad University, Sanandaj

The Effect of a 12-Week Structured Workplace Exercise Program on AGIO Productivity, 360-Degree Performance Evaluation, Herzberg Job Motivation, and Walton Quality of Work Life: A Quasi-Experimental Pre-Test/Post-Test Study in a Medical Garment Manufacturing Factory

This quasi-experimental, single-group pre-test/post-test study is designed to evaluate the effects of a 12-week structured workplace exercise program on four human capital indicators among employees of a medical garment manufacturing factory in Sanandaj, Kurdistan Province, Iran. The study population consists of 150 employees working in production, cutting, quality control, technical maintenance, and administrative departments. Following clinical screening by an occupational medicine specialist and completion of the PAR-Q questionnaire, eligible participants will be enrolled. The exercise intervention consists of 24 sessions (2 sessions per week, 60 minutes each) delivered by a certified fitness instructor. Outcome measures include AGIO human resource productivity, 360-degree performance evaluation, Herzberg job motivation, and Walton quality of work life, assessed at baseline and post-intervention. This study has been approved by the Research Ethics Committee of Islamic Azad University, Sanandaj Branch (IR.IAU.SANANDAJ.REC.1405.152).

Visão geral do estudo

Descrição detalhada

This study employs a quasi-experimental, single-group pre-test/post-test design with a mixed-methods (quantitative-qualitative) approach. The study is conducted at a medical protective apparel and healthcare sanitary wear manufacturing plant in Sanandaj, Kurdistan Province, Iran. Workers primarily perform sedentary-to-light manual tasks including fabric cutting, sewing, quality inspection, and packaging under a two-shift rotation system. The study period runs from April to July 2025 (1 Ordibehesht to 24 Tir 1404, Iranian calendar). Baseline (T1) assessments are completed one week before session 1; post-intervention (T2) assessments are completed within one week of session 24. The study protocol was approved by the Research Ethics Committee of Islamic Azad University, Sanandaj Branch (Ethics Code: IR.IAU.SANANDAJ.REC.1405.152). Written informed consent is obtained from all participants before enrolment.

Participants: All 150 employees of the facility are invited for eligibility screening. A licensed occupational medicine physician conducts clinical examinations supplemented by the Physical Activity Readiness Questionnaire (PAR-Q). Employees with uncontrolled cardiovascular disease, severe respiratory disorders, musculoskeletal conditions incompatible with moderate-intensity exercise, pregnancy, or other physician-identified contraindications are excluded. Eligible employees who provide written informed consent are enrolled. Sample size adequacy is confirmed using Cochran's formula for finite populations (N = 150; 95% CI; margin of error = 0.05; p = q = 0.50), and statistical power is verified using G*Power 3.1.

Intervention Protocol: The 12-week structured exercise program comprises 24 sessions (2 × 60 min/week), delivered by a fitness instructor holding a Grade-2 certification from the Physical Fitness Federation of the Islamic Republic of Iran. Sessions are consistently held at 10:00 AM before shift handovers. The facility's dedicated sports hall provides a climate-controlled environment (25-26°C; 60% relative humidity) consistent with ACSM guidelines for moderate-intensity aerobic exercise. Each session includes a 10-minute warm-up with joint mobility and dynamic stretching, a 40-minute main phase combining intermittent aerobic exercise (60-75% of heart rate reserve) with functional core exercises, calisthenics, and cooperative small-sided games, and a 10-minute cool-down with static stretching, spinal elongation, and guided diaphragmatic breathing. Aerobic intensity is targeted at 60-75% of heart rate reserve using the Karvonen formula, monitored via the Borg Rating of Perceived Exertion (RPE; 6-20 scale; target 12-14). All phases are instructor-led; no self-directed activities are included.

Outcome Measures: Four validated instruments are administered at baseline (T1) and post-intervention (T2). (1) The 40-item Herzberg Dual-Factor Motivation Questionnaire (Darchini, 2015) assesses two independent subscales: Intrinsic/Motivator factors (20 items) and Extrinsic/Hygiene factors (20 items), using a 5-point Likert scale. (2) The 26-item AGIO Human Resource Productivity Scale (Hersey and Blanchard, 1980; validated by Mehri, 2013) assesses seven subscales: Ability, Role Clarity, Organizational Support, Motivation, Feedback, Credibility, and Environmental Fit, using a 5-point Likert scale. (3) A 360-degree performance evaluation questionnaire (Poursoltani et al., 2010) collects ratings from four sources: supervisor, peer, subordinate, and self. (4) The Walton Quality of Work Life Questionnaire (Walton, 1973; Iranian validation by Rahimi, 2005) assesses eight dimensions including fair compensation, safe working conditions, and growth opportunities.

Statistical Analysis Plan: All analyses will use IBM SPSS Statistics v26.0. Composite scale scores (≥ 10 items) will be treated as continuous interval-level data for parametric analyses. Shapiro-Wilk tests will verify univariate normality. For the primary pre-post comparisons, paired-samples t-tests will be used with a Bonferroni-adjusted significance threshold. For the cross-sectional association between post-intervention motivation, 360-degree appraisal, and productivity, an enter-method multiple linear regression will be used. A supplementary regression will include T1 motivation as a covariate. Model assumptions will be verified (VIF < 2.0 for multicollinearity; Durbin-Watson for autocorrelation). One-way ANOVA with partial eta-squared will examine whether demographic characteristics moderate post-intervention outcomes. Qualitative interview data from 10 semi-structured interviews will undergo thematic content analysis (open, axial, and selective coding) as a planned exploratory component of the study.

Tipo de estudo

Intervencional

Inscrição (Real)

109

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Kurdistan Province
      • Sanandaj, Kurdistan Province, Irã, 6616947455
        • PADRA Medical Garment Manufacturing Factory

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  1. Employment at PADRA Medical Garment Manufacturing Factory
  2. Age between 20 and 60 years
  3. Successful completion of clinical examination by an occupational medicine specialist
  4. Successful completion of the PAR-Q (Physical Activity Readiness Questionnaire) with no contraindications
  5. Voluntary written informed consent to participate in the study
  6. Willingness to attend 2 exercise sessions per week for 12 weeks

Exclusion Criteria:

  1. Uncontrolled cardiovascular diseases (e.g., uncontrolled hypertension, recent myocardial infarction)
  2. Severe respiratory disorders (e.g., severe asthma, COPD)
  3. Musculoskeletal problems that contraindicate moderate-intensity physical activity
  4. Any medical contraindication for moderate-intensity exercise as determined by occupational medicine specialist
  5. Pregnancy
  6. Withdrawal of informed consent at any stage of the study
  7. Failure to complete pre-test or post-test questionnaires

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Workplace Exercise Intervention Group
Participants received a 12-week structured workplace exercise program consisting of 24 sessions (60 minutes each, 2 sessions per week). Each session included a 10-minute warm-up with dynamic movements and joint mobilization, a 40-minute main phase combining intermittent aerobic exercise (60-75% of heart rate reserve) with functional endurance training and team-based games (volleyball, small-sided football, passing drills), and a 10-minute cool-down with static stretching, relaxation, and guided diaphragmatic breathing. Exercise intensity was monitored using the Borg Rating of Perceived Exertion (RPE) scale with a target range of 12-14. The intervention was conducted at the factory's adjacent sports hall at 10:00 AM, with ambient temperature maintained at 25-26°C. Attendance was high: 107 out of 109 participants completed ≥22 of 24 sessions. No adverse events or protocol deviations were recorded. Outcomes measured pre- and post-intervention included AGIO productivity, 360-degree perfor
A 12-week structured exercise program consisting of 24 sessions (60 minutes each, 2 sessions per week). Each session includes a 10-minute warm-up with dynamic movements and joint mobilization, a 40-minute main phase combining intermittent aerobic exercise (60-75% of heart rate reserve) with functional endurance training and team-based games (volleyball, small-sided football, passing drills), and a 10-minute cool-down with static stretching, relaxation, and guided diaphragmatic breathing. Intensity monitored by Borg RPE scale (target 12-14). Conducted at factory sports hall, 10:00 AM, 25-26°C. No adverse events recorded.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
AGIO Productivity Score
Prazo: Baseline (Week 0) and Post-Intervention (Week 12)
Measured using the AGIO Human Resource Productivity Scale (Hersey and Blanchard, 1980) with 7 subscales: ability, role clarity, organizational support, motivation, feedback, credibility, and environmental adaptability. Scores range from 1 to 5, with higher scores indicating greater productivity.
Baseline (Week 0) and Post-Intervention (Week 12)
360-Degree Performance Evaluation Score
Prazo: Baseline (Week 0) and Post-Intervention (Week 12)
Description: Measured using the 360-Degree Performance Evaluation Questionnaire (Poursoltani et al., 2010) with 4 sources: supervisor, peer, subordinate, and self. Scores range from 1 to 5, with higher scores indicating better performance.
Baseline (Week 0) and Post-Intervention (Week 12)
Herzberg Job Motivation Score
Prazo: Baseline (Week 0) and Post-Intervention (Week 12)
Measured using the Herzberg Dual-Factor Motivation Questionnaire (Darchini, 2015) assessing intrinsic (motivational) and extrinsic (hygiene) factors. Scores range from 1 to 5, with higher scores indicating greater job motivation.
Baseline (Week 0) and Post-Intervention (Week 12)
Walton Quality of Work Life Score
Prazo: Baseline (Week 0) and Post-Intervention (Week 12)
Measured using the Walton Quality of Work Life Questionnaire (Walton, 1973; Iranian validation by Rahimi, 2005) with 8 dimensions including fair compensation, safe working conditions, and growth opportunities. Scores range from 1 to 5, with higher scores indicating better quality of work life.
Baseline (Week 0) and Post-Intervention (Week 12)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
AGIO Subscale Scores
Prazo: Baseline (Week 0) and Post-Intervention (Week 12)
Individual subscale scores of the AGIO Human Resource Productivity Scale (Hersey and Blanchard, 1980) including Ability, Role Clarity, Organizational Support, Motivation, Feedback, Credibility, and Environmental Fit. Each subscale score ranges from 1 to 5, with higher scores indicating greater productivity.
Baseline (Week 0) and Post-Intervention (Week 12)
Herzberg Factor Scores
Prazo: Baseline (Week 0) and Post-Intervention (Week 12)
Separate scores for the Intrinsic/Motivator factors and Extrinsic/Hygiene factors of the Herzberg Dual-Factor Motivation Questionnaire (Darchini, 2015). Each factor score ranges from 1 to 5, with higher scores indicating greater job motivation.
Baseline (Week 0) and Post-Intervention (Week 12)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

21 de abril de 2002

Conclusão Primária (Real)

15 de julho de 2025

Conclusão do estudo (Real)

15 de julho de 2025

Datas de inscrição no estudo

Enviado pela primeira vez

7 de setembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de setembro de 2026

Primeira postagem (Real)

17 de setembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever